Evaluation of the relationship between plasma viscosity and selected menopausal symptoms using the Menopause Rating Scale.

Creative Commons License

Korkmaz H., Arslanca T., Tekin E., Kayabaşi B., Akbulut K. G.

Menopause (New York, N.Y.), no.00, 2022 (SCI-Expanded) identifier

  • Publication Type: Article / Article
  • Publication Date: 2022
  • Doi Number: 10.1097/gme.0000000000002017
  • Journal Name: Menopause (New York, N.Y.)
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, CINAHL, EMBASE, MEDLINE, Veterinary Science Database
  • Gazi University Affiliated: Yes



Objective: The aim of this study was to investigate whether whole blood viscosity and plasma viscosity are associated with the severity of postmenopausal symptoms using the Menopause Rating Scale (MRS).

Methods: This study included 108 postmenopausal women admitted to menopause clinics. Participants were divided into two groups according to their MRS scores. Groups 1 (n = 52) and 2 (n = 56) were composed of healthy postmen- opausal women with MRS scores of <14 and 14 points, respectively. The clinical findings and hemorheological pa- rameters were compared between the two groups.

Results: Comparing plasma viscosity levels between the two groups showed that group 1 had 1.25 ± 0.08 centipoise, whereas group 2 had 1.30 ± 0.10 centipoise ( = 0.03). The difference in plasma viscosity between the two groups persisted after adjustment for age (1.24 ± 0.08 vs 1.31 ± 0.10; < 0.001). Plasma viscosity was also significantly cor- related with age (= 0.384, < 0.001), menopausal duration (= 0.362, < 0.001), and urogenital symptoms (= 410, < 0.001).

Conclusions: Increased plasma viscosity levels were significantly associated with selected postmenopausal symp- toms, independent of age.

Key Words: Hemorheology – Menopausal symptoms – Menopause Rating Scale – Plasma viscosity – Urogenital symptoms.